Almirall, S.A.
Almirall, S.A. (LBTSF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lbtsf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Almirall, S.A. (LBTSF) measures how much investors pay for each dollar of the company's trailing earnings. LBTSF's current PE ratio of 45.40x is calculated by dividing its stock price of $15.35 by its TTM earnings per share of $0.24. −67.5% discount vs 5Y avg 139.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 16 fiscal years · Front-end computedMinQ1 · 25%16.7x
MedianQ3 · 75%381.7x
Max
At 45.40x, LBTSF's current P/E is higher than in 81% of its annual fiscal year readings over the past 16 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Almirall, S.A.You LBTSF | $3.3B | 45.40x | -38.8% | $0.24 |
 Fagron N.V. ARSUF | $2.0B | 16.06x | -78.3% | $1.25 |
 CanSino Biologics Inc. CASBF | $1.4B | 309.29x | +316.9% | $0.11 |
 China Medical System Holdings Limited CHSYF | $2.3B | 15.75x | -78.8% | $0.60 |
 Curaleaf Holdings, Inc. CURLF | $3.0B | N/A | — | -$0.93 |
 Dermapharm Holding SE DMPHF | $2.9B | 13.70x | -81.5% | $2.46 |
 Green Thumb Industries Inc. GTBIF | $2.0B | 16.19x | -78.2% | $0.50 |
Industry Average 5 peers with valid PE | — | 74.20x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 61.23x | $0.22 | -70.0% | |
2024-12-31 FY2024 | 204.31x | $0.04 | — | |
2023-12-31 FY2023 | — | $-0.20 | — | |
2022-12-31 FY2022 | 381.71x | $0.02 | — | |
2021-12-31 FY2021 | — | $-0.23 | — | |
2020-12-31 FY2020 | 23.93x | $0.42 | -14.8% | |
2019-12-31 FY2019 | 28.08x | $0.61 | -15.8% | |
2018-12-31 FY2018 | 33.33x | $0.41 | — | |
2017-12-31 FY2017 | — | $-1.76 | — | |
2016-12-31 FY2016 | 32.86x | $0.44 | +56.4% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Almirall, S.A. (LBTSF) measures how much investors pay for each dollar of the company's trailing earnings. LBTSF's current PE ratio of 45.40x is calculated by dividing its stock price of $15.35 by its TTM earnings per share of $0.24.
Frequently asked questions
LBTSF pe ratio · 6 questionsLBTSF's current PE ratio is 45.40x as of 2026-06-09, based on a stock price of $15.35 and TTM EPS of $0.24. Data sourced from Financial Modeling Prep via LBTSF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Almirall, S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09